According to a study just published in the European Heart Journal, working 3 to 4 extra hours a day is associated with increased risk for coronary heart disease (CHD).
More than 6,000 British government workers aged 39-61 with no evidence of heart disease at baseline were followed for an average of 11 years. The outcome measures were fatal CHD, clinically verified non-fatal myocardial infarction or confirmed angina.
After adjustment for lifestyle, conventional cardiac risk factors, and other potential confounders, participants who worked 3 to 4 hours of overtime a day, beyond the standard 7–8 hours/day, faced a 60% increase in risk for CHD, compared with those who didn’t work any overtime.
Those who worked overtime for 1–2 hours/day did not show increased risk.
Word on Health would love to tell you more but our hearts are telling us it’s time to go!
Doctors in the United States wrote more than four million prescriptions for nitroglycerin tablets last year. Commonly referred to as nitro, these under-the-tongue pills are used to relieve chest pain associated with heart disease (angina) or to stop a heart attack (myocardial infarction).
However, the doctors who prescribed these drugs and the patients who took them have just learned that about 80% of the drugs dispensed had not been approved by the Food and Drug Administration (FDA).
Worse still doctors have no way of knowing whether patients may have suffered unnecessarily as a result.
“If it’s not approved and no one has tested it, we can’t be sure that it’s safe and effective,” warned Dr. Harry M. Lever, a cardiologist at the Cleveland Clinic.
The FDA sent warning letters in late March to suppliers of the unapproved tablets giving them 90 days to stop making the drugs and 180 days to stop shipping them.
The FDA said that it had not examined the quality of the products it was ordering off the market but that it had recorded problems with other unapproved nitroglycerin products in the past. The agency advised people who take unapproved nitroglycerin to continue taking their tablets but to consult their doctors about replacement prescriptions.
The two companies involved: Konec Inc. and Glenmark Generics Inc. said they would comply with the order, but declared that their tablets were safe.
Only one brand of nitroglycerin pills is FDA approved: Pfizer’s Nitrostat. Pfizer says it has stepped up production of the drug and expects to be able to meet the entire US market demand.